In addition to conventional Luminex bead-based multiplex assays and ELISAs as a broad initial analysis for
biomarker profiling, our high-sensitivity singleplex and multiplex assays are established upon MSD-ECL
(Meso Scale Diagnostics-Electrochemiluminescence) technology platform to detect biomarkers difficult or
impossible to measure with conventional assays. The Electrochemiluminescence nature of the MSD technology
allows an average of 100x sensitivity increase over conventional assays with CVs <10%.
We provide the most cost-effective high-sensitivity testing services on MSD-ECL technology platform to
measure the following biomarkers with quality assurance and capability of custom assay development: